Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-29 @ 1:12 AM
Study NCT ID:
NCT05485766
Status:
RECRUITING
Last Update Posted:
2025-03-20
First Post:
2022-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
Sponsor:
Okayama University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-16
Start Date Type:
ACTUAL
Primary Completion Date:
2028-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-01
First Submit QC Date:
None
Study First Post Date:
2022-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-17
Last Update Post Date:
2025-03-20
Last Update Post Date Type:
ACTUAL